|
2007 Journal Article Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic propertiesHoang, A., Murphy, A. J., Coughlan, M. T., Thomas, M. C., Forbes, J. M., O'Brien, R., Cooper, M. E., Chin-Dusting, J. P. F. and Sviridov, D. (2007). Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia, 50 (8), 1770-1779. doi: 10.1007/s00125-007-0718-9 |
|
2007 Journal Article Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?Coughlan, Melinda T., Thallas-Bonke, Vicki, Pete, Josefa, Long, David M., Gasser, Anna, Tong, David C. K., Arnstein, Maryann, Thorpe, Suzanne R., Cooper, Mark E. and Forbes, Josephine M. (2007). Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?. Endocrinology, 148 (2), 886-895. doi: 10.1210/en.2006-1300 |
|
2007 Journal Article AGE, RAGE, and ROS in diabetic nephropathyTon, Adeline L. Y., Forbes, Josephine M. and Cooper, Mark E. (2007). AGE, RAGE, and ROS in diabetic nephropathy. Seminars in Nephrology, 27 (2), 130-143. doi: 10.1016/j.semnephrol.2007.01.006 |
|
2007 Journal Article Renal microvascular injury in diabetes: RAGE and redox signalingCoughlan, Melinda T., Cooper, Mark E. and Forbes, Josephine M. (2007). Renal microvascular injury in diabetes: RAGE and redox signaling. Antioxidants and Redox Signaling, 9 (3), 331-342. doi: 10.1089/ars.2006.1469 |
|
2007 Conference Publication Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetesCoughlan, M. T., Forbes, J. M. and Cooper, M. E. (2007). Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes. 5th Hyonam-Kidney-Laboratory-International-Diabetes Symposium, Seoul South Korea, Feb 02-03, 2007. Nature Publishing Group. doi: 10.1038/sj.ki.5002387 |
|
2007 Journal Article Diabetic nephropathy: where hemodynamics meets metabolismForbes, J. M., Fukami, K. and Cooper, M. E. (2007). Diabetic nephropathy: where hemodynamics meets metabolism. Experimental and Clinical Endocrinology and Diabetes, 115 (2), 69-84. doi: 10.1055/s-2007-949721 |
|
2006 Journal Article Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal diseaseBurns, Wendy C., Twigg, Stephen M., Forbes, Josephine M., Pete, Josefa, Tikellis, Christos, Thallas-Bonke, Vicki, Thomas, Merlin C., Cooper, Mark E. and Kantharidis, Phillip (2006). Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. Journal of the American Society of Nephrology, 17 (9), 2484-2494. doi: 10.1681/ASN.2006050525 |
|
2006 Conference Publication Diabetes-induced effects on endothelial function and the actions of nitric oxideSoro-Paavonen, A., Zhang, W. -Z., Venardos, K., Jones, E., Chin-Dusting, J., Thomas, M. T., Coughlan, M. T., Brasacchio, D., Cooper, M. E., Kaye, D. and Forbes, J. M. (2006). Diabetes-induced effects on endothelial function and the actions of nitric oxide. 42nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Copenhagen Denmark, Sep 14-17, 2006. SPRINGER. |
|
2006 Journal Article A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-productsZimanyi, M. A., Denton, K. M., Forbes, J. M., Thallas-Bonke, V., Thomas, M. C., Poon, F. and Black, M. J. (2006). A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products. Diabetologia, 49 (4), 801-810. doi: 10.1007/s00125-006-0175-x |
|
2006 Journal Article Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823))Forbes, J. M., Yee, L. T.L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., Cooper, M. E. and Allen, T. J. (2006). Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823)). Diabetes, 55 (3) |
|
2006 Journal Article Novel therapeutics for diabetic micro- and macrovascular complicationsSoro-Paavonen, A. and Forbes, J. M. (2006). Novel therapeutics for diabetic micro- and macrovascular complications. Current Medicinal Chemistry, 13 (15), 1777-1788. doi: 10.2174/092986706777452515 |
|
2005 Conference Publication Advanced glycation end products and diabetic nephropathyThomas, Merlin C., Forbes, Josephine M. and Cooper, Mark E. (2005). Advanced glycation end products and diabetic nephropathy. doi: 10.1097/01.mjt.0000178769.52610.69 |
|
2005 Journal Article Interactions between renin angiotensin system and advanced glycation in the kidneyThomas, Merlin C., Tikellis, Christos, Burns, Wendy M., Bialkowski, Katarzyna, Cao, Zemin, Coughlan, Melinda T., Jandeleit-Dahm, Karen, Cooper, Mark E. and Forbes, Josephine M. (2005). Interactions between renin angiotensin system and advanced glycation in the kidney. Journal of the American Society of Nephrology, 16 (10), 2976-2984. doi: 10.1681/ASN.2005010013 |
|
2005 Journal Article Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsCalkin, Anna C., Forbes, Josephine M., Smith, Craig M., Lassila, Markus, Cooper, Mark E., Jandeleit-Dahm, Karin A. and Allen, Terri J. (2005). Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 (9), 1903-1909. doi: 10.1161/01.ATV.0000177813.99577.6b |
|
2005 Journal Article Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathyForbes, Josephine M., Thorpe, Suzanne R., Thallas-Bonke, Vicki, Pete, Josefa, Thomas, Merlin C., Deemer, Elizabeth R., Bassal, Sahar, El-Osta, Assam, Long, David M., Panagiotopoulos, Sianna, Jerums, George, Osicka, Tanya M. and Cooper, Mark E. (2005). Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. Journal of the American Society of Nephrology, 16 (8), 2363-2372. doi: 10.1681/ASN.2005010062 |
|
2005 Journal Article High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionKooptiwut, Suwattanee, Kebede, Melkam, Zraika, Sakeneh, Visinoni, Sherley, Aston-Mourney, Kathryn, Favaloro, Jenny, Tikellis, Chris, Thomas, Merlin C., Forbes, Josephine M., Cooper, Mark E., Dunlop, Marjorie, Proietto, Joseph and Andrikopoulos, Sofianos (2005). High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. Journal of Molecular Endocrinology, 35 (1), 39-48. doi: 10.1677/jme.1.01720 |
|
2005 Journal Article Agents in development for the treatment of diabetic nephropathyFukami, Kei, Cooper, Mark and Forbes, Josephine M. (2005). Agents in development for the treatment of diabetic nephropathy. Expert Opinion On Investigational Drugs, 14 (3), 279-294. doi: 10.1517/13543784.14.3.279 |
|
2005 Conference Publication Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?Forbes, JM, Coughlan, MT, Fukami, K, Laskowski, A, Thallas-Bonke, V, Dinh, D, Long, DM, Brownlee, M, Cooper, ME and Thorburn, DR (2005). Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER. |
|
2005 Conference Publication Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?Thomas, Merlin C., Forbes, Josephine M., MacIsaac, Richard, Jerums, George and Cooper, Mark E. (2005). Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?. New York Academy of Sciences. doi: 10.1196/annals.1333.073 |
|
2005 Conference Publication Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?Coughlan, Melinda T., Cooper, Mark E. and Forbes, Josephine M. (2005). Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?. New York Academy of Sciences. doi: 10.1196/annals.1333.087 |
